LBR
LBR (dba LBRIA) is a US-based full-service Contract Research Organization (CRO) offering integrated regulatory, clinical, biometrics, data management, and QA services to start-ups and small-to-mid-sized drug, biotech, and medical device companies across multiple therapeutic areas.
- Company typePrivate
- Founded2001
- HeadquartersFlorence, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LBR does
LBR (doing business as LBRIA) is a full-service Contract Research Organization (CRO) headquartered in Florence, Kentucky, founded in 2001 and co-founded and owned by Lois Rosenberger and Stephen M. Rosenberger. The company delivers integrated clinical and regulatory services across seven modules: Regulatory Services, Medical Writing, Biometric Services, Clinical Trial Services, Clinical Programming, Data Management, and Quality Assurance, supporting drug, biotech, and medical device sponsors from early development through regulatory authorization submissions with the FDA, Health Canada, EMA, and PMDA.
LBRIA's primary customer base is start-ups and small-to-mid-sized drug and biotech companies that require external regulatory and clinical expertise to navigate complex development pathways. The company also serves international sponsors as an FDA Authorized Representative and offers independent regulatory and clinical expertise to investors and legal professionals. Therapeutic-area coverage spans addiction, analgesics, anti-inflammatory, cardiovascular, endocrinology, gastroenterology, neurology, oncology, pediatric and adult rare diseases, women's health, and vaccines. The firm operates with 11-50 employees and does not publicly disclose pricing.
The business model is services-based: project and program-level CRO engagements billed on FTE, fixed-fee, or milestone structures typical of the sector, with revenue derived from regulated clinical trial execution, regulatory submission preparation, medical writing, biometrics, data management, and GCP-compliant QA. Distribution is direct via the company website (lbria.com) and PR/news distribution channels for announcements, with no disclosed app, platform, or third-party distribution partnerships specific to the CRO business.
LBR firmographics
Firmographics- Name
- LBR
- Legal name
- LBR
- Website
- https://lbr-regulatory.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LBR (dba LBRIA) is a US-based full-service Contract Research Organization (CRO) offering integrated regulatory, clinical, biometrics, data management, and QA services to start-ups and small-to-mid-sized drug, biotech, and medical device companies across multiple therapeutic areas.
- Ownership category
- akta.pro rank
LBR industry classification
Industry- Product category
- Contract Research Organization Services
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
Keywords
Where LBR is headquartered
LocationHeadquarters
- HQ city
- Florence
- HQ country
- United States
- HQ region
- North America
Markets served
LBR business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Marketing channels1 record
LBR product offering
Product offeringCore offering
LBR (operating as LBRIA) is a full-service Contract Research Organisation (CRO) providing integrated clinical and regulatory services for drug, biotech, and medical device innovators. The company delivers end-to-end support from early development through regulatory authorization submissions to FDA, Health Canada, EMA, and PMDA, including regulatory strategic planning, clinical trial execution, regulatory and medical writing, biometrics, clinical programming, data management, and quality assurance.
Product overview
LBRIA is a full-service Contract Research Organisation (CRO) offering integrated clinical and regulatory services as a unified platform. The company provides seven core service modules including Regulatory Services, Medical Writing, Biometric Services, Clinical Trial Services, Clinical Programming, Data Management, and Quality Assurance. These services are designed to work together to deliver end-to-end support for drug, biotech, and medical device innovators from early development through regulatory authorization submissions.
Differentiator
Problem solved
Functional benefit
Products and services
- Regulatory Services
- Medical Writing
- Biometric Services
- Clinical Trial Services
- Clinical Programming
- Data Management
- Quality Assurance
Companies that use LBR
Customer profileSegments1 record
Ideal customer profiles1 record
LBR technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
LBR partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ALMcoreALM and LBR recently merged to form a global information company serving the legal industry. The merger combines ALM's and LBR's resources and platforms to create a comprehensive legal industry information and research company.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
LBR competitors and assessment
Company assessmentBroad incumbents
- Parexel International:
- Labcorp Drug Development (formerly Covance): Global CRO arm of Labcorp providing clinical, biometrics, central lab, and regulatory services. Direct full-service competitor with broader geographic reach and lab infrastructure.
- IQVIA: World's largest CRO with end-to-end clinical, regulatory, biometrics, and real-world evidence services. Directly comparable full-service scope, but at vastly greater scale and weighted to large-pharma sponsors.
- ICON plc: Global full-service CRO offering clinical, biometrics, regulatory, and laboratory services post-PRA merger. Comparable full-service breadth and multi-jurisdictional regulatory capability, at much larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
LBR social profiles
Digital presenceLBR financial estimates
Financial estimateRevenue estimate
Valuation estimate
LBR leadership team
Management profileNumber of profiles
Profiles2 records
LBR funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LBR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LBR
What does LBR do?
LBR (operating as LBRIA) is a full-service Contract Research Organisation (CRO) providing integrated clinical and regulatory services for drug, biotech, and medical device innovators. The company delivers end-to-end support from early development through regulatory authorization submissions to FDA, Health Canada, EMA, and PMDA, including regulatory strategic planning, clinical trial execution, regulatory and medical writing, biometrics, clinical programming, data management, and quality assurance.
Is LBR a public or private company?
LBR is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LBR founded?
LBR was founded in 2001. It employs 11 to 50 people.
Where is LBR based?
LBR is headquartered in Florence, United States, in the North America region.
Who are LBR's main competitors?
Broad incumbents on record are Parexel International, Labcorp Drug Development (formerly Covance), IQVIA and ICON plc.
Does LBR have an API?
No public API is recorded for LBR.
What industry is LBR in?
LBR's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP).